Update on the management of neonatal sepsis based on evidence and international guidelines
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Neonatal sepsis remains a major cause of morbidity and mortality worldwide, particularly among preterm and low birth weight infants. Its pathophysiology is closely linked to immune immaturity, characterized by functional neutrophil deficits, reduced opsonization and complement activity, and a limited adaptive immune response. Once infection is established, an exaggerated inflammatory cascade involving proinflammatory cytokines contributes to endothelial dysfunction, capillary leak, microcirculatory impairment, metabolic acidosis, and ultimately multi-organ failure. These mechanisms are especially severe in premature infants due to their physiological vulnerability. Globally, the incidence of neonatal sepsis has increased over recent decades, although mortality has declined, reflecting advances in clinical care. However, the burden remains disproportionately high in low- and middle-income countries. The epidemiology varies according to timing of onset, with early-onset sepsis commonly caused by Group B Streptococcus and Escherichia coli, and late-onset sepsis more frequently associated with coagulase-negative staphylococci and Gram-negative organisms. Rising antimicrobial resistance, exacerbated during the coronavirus disease pandemic, further complicates empirical treatment strategies. Clinical presentation is often non-specific, including thermal instability, lethargy, and respiratory distress, which may progress to hypotension, oliguria, and neurological impairment. Diagnosis relies on blood cultures as the gold standard, complemented by laboratory markers such as C-reactive protein and procalcitonin, although limitations in sensitivity persist. Management requires timely empirical antibiotics tailored to gestational age and onset timing, followed by culture-guided adjustment and de-escalation. Comprehensive care includes fluid resuscitation, vasoactive support, respiratory management, metabolic stabilization, and continuous monitoring. Prevention strategies, antimicrobial stewardship, and emerging molecular diagnostics are essential to improve outcomes and address ongoing challenges.
Fields of Study & Subjects
Neonatal and Maternal Infections
Sepsis Diagnosis and Treatment
Streptococcal Infections and Treatments
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 28 March 2026
- Language
- EN